Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T17:07:15.125Z.
Calculation as of: 2026-10-06T17:07:15.125Z.
Quote observation: 2026-10-06T16:55:26.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 87a3ef4e55b06d985fb23947e4d9ae6563d80488a3a61227015f8099389db825
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$859749.00
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$874437.00
EV/FCF Ratio
N/A
TTM Avg
837938.26x
3Y Avg
5687338.31x
5Y Avg
5687338.31x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCW Biologics Inc. (HCWB) | $559702.00 | N/A | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $487356.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $674156.00 | N/A | 2.87x | 2.87x | 2.87x |
| Niki BioSolutions, Inc. (NIKI)vs › | $381125.00 | N/A | N/A | N/A | N/A |
| Ridgetech, Inc. (RDGT)vs › | $791587.00 | N/A | 3.75x | 3.71x | 2.08x |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $842981.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $859749.00 | N/A | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $851149.00 | N/A | N/A | N/A | N/A |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $874437.00 | N/A | 837938.26x | 5687338.31x | 5687338.31x |
| SciSparc Ltd. (SPRC)vs › | $243502.00 | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
